Posted on February 9, 2016 by Sitemaster
Today’s news contained items that run the spectrum from the clinical value of tomatoes and lycopene via the cardiovascular side effects of LHRH agonists and antagonists to the question of whether proton beam radiation therapy is really cost-effective. So here are the “news shorts” for the day: … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention, Risk, Treatment | Tagged: agonist, antagonist, cost-effectiveness, LHRH, lycopene, proton beam, PSA density, side effect, testosterone, tomato | 3 Comments »
Posted on July 1, 2014 by Sitemaster
On June 5 we had noted that, the day before, the American Society for Radiation Oncology (ASTRO) released its model policy on the use of proton beam radiation therapy (PBRT) and related reimbursement issues. … READ MORE …
Filed under: Management, Treatment, Uncategorized | Tagged: ASTRO, PBRT, policy, proton beam, radiation | 7 Comments »
Posted on August 1, 2013 by Sitemaster
Apparently the British National Health Service has decided to stump up £250 million (equivalent to US$380 million) to build two proton beam radiation therapy (PBRT) units in the UK. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: proton beam, radiation, UK | 2 Comments »
Posted on April 13, 2012 by Sitemaster
Apparently the powers that be in the UK have decided to shell out the money to build two (small) proton beam radiation therapy (PBRT) units in the UK — one in London and one in Manchester. The media coverage suggests that they will be used primarily for the treatment of rare cancers in children. The centers are scheduled to come on line in 2017. … READ MORE …
Filed under: Management, Treatment | Tagged: cost, PBRT, proton beam, UK | 1 Comment »
Posted on March 29, 2012 by Sitemaster
People have strong views about the clinical use of proton beam radiation therapy (PBRT) in the management of localized prostate cancer. The Emerging Technology Committee of the American Society of Radiation Oncology (ASTRO) has now published a report of the applicability of PBRT in many forms of cancer, including prostate cancer. … READ MORE …
Filed under: Management, Treatment | Tagged: expert, proton beam, radiation, report | Leave a comment »
Posted on March 26, 2012 by Sitemaster
Ye of faith … and ye of rather less faith … in the merits of proton beam radiation therapy (PBRT) compared to other forms of treatment for management of localized prostate cancer may want to read through Robert Langreth’s article (“Prostate cancer therapy too good to be true explodes health cost“) posted this morning on the Bloomberg.com web site. … READ MORE …
Filed under: Management, Treatment | Tagged: cost, PBRT, proton beam, radiation therapy, value | 13 Comments »
Posted on February 21, 2012 by Sitemaster
According to a recently published research letter, men with prostate cancer who live close to the Loma Linda proton beam radiation therapy (PBRT) center are five times more likely to choose PBRT for their treatment than are other men who live in California but don’t live close to Loma Linda! DUH! … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: Loma Linda, PBRT, proton beam | 2 Comments »
Posted on February 1, 2012 by Sitemaster
For the first time, some 15 years after proton beam radiation therapy (PBRT) was initially popularized as a potential treatment for prostate cancer by the group at Loma Linda, we have an independent assessment of the risk for side effects associated with this form of radiation therapy … and the comparative data are not good. … READ MORE …
Filed under: Management, Treatment | Tagged: IMRT, outcome, proton beam, radiation therapy, safety | 8 Comments »
Posted on January 6, 2012 by Sitemaster
Posted on September 15, 2011 by Sitemaster
A new article in this month’s issue of The ASCO Post addresses the need for concrete evidence that proton beam radiation therapy (PBRT) is actually “better” than modern forms of photon-based external beam radiation therapy (EBRT) in the management of prostate cancer (and other forms of cancer). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: outcome, photon, proton beam, radiation therapy, relative | 17 Comments »
Posted on July 12, 2011 by Sitemaster
Three new articles in the June 15 issue of Oncology review the current data and the potential of proton beam radiation therapy (PBRT) as a first-line treatment for localized prostate cancer. The full texts of all three articles are available on line. … READ MORE …
Filed under: Management, Treatment | Tagged: cost, lozalized, outcome, PBRT, proton beam, radiation therapy | 7 Comments »
Posted on November 8, 2010 by Sitemaster
A new article on the WebMD web site appears under the heading “Targeted radiation may help men avoid impotence,” but it is the incidence of adverse genitourinary (GU) obstructive symptoms during and after treatment that is of greater interest to The “New” Prostate Cancer InfoLink. … READ MORE …
Filed under: Management, Treatment | Tagged: adverse effect, erectile function, genitourinary, obstructive, ouctome, PBRT, proton beam, radiation | 5 Comments »
Posted on October 5, 2010 by Sitemaster
Over the years there have been almost no publications addressing the complications of proton beam radiation therapy (PBRT) among well-defined series of prostate cancer patients. With the number of PBRT centers now growing fast, good data on the side effects of PBRT are an urgent priority. … READ MORE …
Filed under: Management, Treatment | Tagged: complications, PBRT, proton beam, toxicity | 5 Comments »
Posted on May 21, 2010 by Sitemaster
The American Society for Radiation Oncology (ASTRO) has issued a draft technical report from the Evaluation Subcommittee of their Emerging Technologies Committee dealing with the evolution and current status and uses of proton beam radiation therapy (PBRT). … READ MORE …
Filed under: Management, Treatment | Tagged: PBRT, proton beam, radiation therapy | Leave a comment »
Posted on June 26, 2009 by Sitemaster
Today’s prostate cancer news report summary includes items dealing with:
- The epigenetics of prostate cancer and their potential importance
- Selenium + vitamin E + lycopene (in mice)
- Gleason 7: 4 + 3 versus 3 + 4 — it’s important
- Proton beam radiotherapy — a topical review
- EBRT + low dose, permanent seed brachytherapy … READ MORE …
Filed under: Diagnosis, Management, Prevention, Risk, Treatment | Tagged: brachytherapy, EBRT, epigenetics, Gleason 3 + 4 4 + 3, lycopene, PBRT, proton beam, selenium, vitamin E | 2 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 